Abstract
Fifteen years ago, when the first International Meeting of Pharmaceutical Physicians (IMPP) took place in London, multicentre trials received only a marginal mention in one paper, that of McNicol [1], an investigator from academe, who in his conclusions emphasized their difficulties. Curiously enough, the same difficulties were expressed by Temple of the Food and Drug Administration in 1986 [2]. Thus, even though multicentre trials have reached a high degree of popularity nowadays, the subject is still controversial.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Reference
McNicol G P. In: Jouhar A J, Grayson M F, eds. International Aspects of Drug Evaluation and Usage, Edinburgh and London: Churchill Livingstone, 1973;293–300.
Temple R. Effective design of clinical studies. Drug info J 1986;20:127–33.
Joyce C R B. In: Lucchelli P E, Bergamini N, Bachini V, eds. Rationality of Drug Development, Amsterdam and New York: Excerpta Medica, 1976; 17–20.
Lucchelli P E, Baroni L, Basagni M. Analisi del giudizio clinico in reumatologia. In: Fuccella L M, ed. Farmaci antiinfiammatori. Aspetti della valutazione preclinica e clinica, Milano: Informedica, 1977; 133–41.
Gruppo Italiano per lo Studio della Streptochinasi nell’ Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397–402.
Lucchelli P E, Motolese M. Aspetti metodologici ed organizzativi delle ricerche policentriche. Boll Chim Farm 1972;111:83–92.
Polli E, Barbieri D, Bonomo E, et al. Sperimentazione policentrica pianificata con diuretici nella cirrosi epatica ascitogena. Atti Accad Med Lomb 1963;18:1065–89.
Lucchelli P E. Clinical trials and the general practioner. In: Steichele C, Abshagen U, Koch-Weser J, eds. Drugs between Research and Regulations, New York: Steinkopff Verlag Darmstadt, Springer-Verlag, 1985;51–6.
Sylvester R J, Pinedo HM, De Pauw M, et al. Quality of institutional participation in multicentre clinical trials. N Engl J Med 1981;305:852–5.
Pace F, Blum A L. The multicentre trial: does it solve or create problems? Ital J Gastroenter 1981;13:260–7.
De Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177–88.
Editor information
Editors and Affiliations
Copyright information
© 1988 The International Federation of Associations of Pharmaceutical Physicians
About this chapter
Cite this chapter
Lucchelli, P.E. (1988). Multicentre trials in drug development: good? necessary?. In: Burley, D., Haward, C., Mullinger, B. (eds) The Focus for Pharmaceutical Knowledge. Palgrave, London. https://doi.org/10.1007/978-1-349-09571-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-349-09571-1_14
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-09573-5
Online ISBN: 978-1-349-09571-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)